Just a Little Pinprick

I am writing in reference to your editorial.1 In my opinion, your "harsh vent" against antivaccine groups was (to say the least) unnecessary. It is true that there are inflammatory reports about treatments and scientific discoveries. However, we cannot forget that this takes place even in peer-reviewed scientific journals. I don't belong to any of these antivaccine groups. But, these groups provide a healthy equilibrium, which is beneficial to society. After all, a theory (in this case a treatme


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I am writing in reference to your editorial.1 In my opinion, your "harsh vent" against antivaccine groups was (to say the least) unnecessary. It is true that there are inflammatory reports about treatments and scientific discoveries. However, we cannot forget that this takes place even in peer-reviewed scientific journals. I don't belong to any of these antivaccine groups. But, these groups provide a healthy equilibrium, which is beneficial to society. After all, a theory (in this case a treatment) needs to outdo the scrutiny of people and time in order to validate itself.

Irving E. Vega, PhDResearch FellowDepartment of Neuroscience Mayo Clinic Jacksonville, Fla.Vega.Irving@mayo.edu

***

In response to the excellent editorial, 1 we would like to point out that there are multiple efforts attempting to counteract the misinformation surrounding vaccines. Groups working to provide accurate and reliable vaccine information include: the Vaccine Education Center at The Children's Hospital of Philadelphia ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio